Biotech Startups

Kodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.

0 investors

Koios Medical develops FDA-cleared, CE-marked AI software that assists physicians in diagnosing breast and thyroid cancer from ultrasound images. The product aims to reduce missed cancers and improve workflow efficiency for radiologists and clinical sites.

0 investors

0 investors

0 investors

0 investors

0 investors

0 investors

0 investors

Koutif Therapeutics develops therapeutic compounds that inhibit the inflammatory cascade by targeting the ubiquitin degradation pathway, specifically using an inhibitor of the Fbxo3 E3 ligase to degrade pro-inflammatory proteins such as TRAFs and the NLRP3 inflammasome. Its drug discovery approach is based on intellectual property licensed from the University of Pittsburgh and the U.S. Department of Veterans Affairs, aimed at treating inflammatory conditions.

0 investors

Koyo Sciences is a biotechnology company developing an oral human growth hormone therapy derived from algae as a non-invasive alternative to injectable treatments for Growth Hormone Deficiency. Its research spans biology, chemistry, and data with a focus on health and sustainability.

0 investors

0 investors

0 investors

Kraig Biocraft Laboratories develops spider silk-based high-performance technical fibers engineered for strength, toughness, and flexibility, targeting military, industrial, and consumer applications. The company uses genetic engineering and biotechnology, working with research institutions such as the University of Notre Dame.

0 investors

Kromatid provides single-cell structural genomic analysis tools for cell and gene therapy companies, enabling assessment of genomic integrity and identification of complex structural rearrangements during therapy development. The company serves biotech and medtech organizations working on gene editing and cell therapy from early research through clinical trials.

0 investors

Kuleana Technology develops portable dialysis technology for patients with chronic kidney failure and end-stage renal disease, including a dialysis machine that runs without a constant water connection and a needleless vascular access system. The company, formed by doctors, scientists, and engineers, advances technology from the University of Washington's Center for Dialysis Innovation to enable at-home, flexible dialysis.

0 investors

Kurin manufactures blood culture collection sets with contamination-reducing technology for healthcare providers. The company provides clinical support, data analytics, and outcomes measurement through proprietary platforms.

0 investors

Praxis is a nonprofit venture-building ecosystem that supports early-stage businesses and nonprofits founded by Christian entrepreneurs focused on redemptive impact. The organization provides founder formation programs, connects faith-aligned capital to portfolio ventures, and builds community among entrepreneurs pursuing purpose-driven ventures across all sectors.

0 investors

0 investors

LAACClamp Inc develops a curved surgical clamp designed to fully close the heart's left atrial appendage to reduce stroke risk in cardiac surgery patients. The device, currently in preclinical development, is intended for cardiac surgeons and uses off-the-shelf surgical instruments instead of complex delivery systems.

0 investors

0 investors

0 investors

0 investors

Lakewood Amedex develops antimicrobial compounds, specifically Bisphosphocin® formulations, designed as locally delivered bactericides and fungicides with potential medical applications. The company focuses on advancing antimicrobial technology to address infection treatment needs.

0 investors

0 investors